BALL — Q2 2026 Earnings Preview

BUY
NYSE: BALL  | Aluminum-can compounder into Aug 4 BMO: 10%+ FY26 comparable EPS algorithm reaffirmed after a clean Q1 double-beat; Street at ~$0.99 EPS / ~$3.69B sales with Millersburg $35M startup still H2-weighted and NCA capacity-capped until 2027.
Earnings Date
Aug 4
Tue · BMO · call 8:30 a.m. ET · ~3 days
Consensus Comp EPS
~$0.99
FMP $0.989 · +~10% YoY vs $0.90 Q2'25
Consensus Sales
~$3.69B
+~10% YoY vs $3.34B Q2'25
FY26 Guide
10%+ comp EPS
FCF >$900M · reaffirmed Q1

Setup in one line

Q1 delivered comparable EPS $0.94 (+24% YoY) on net sales $3,603M (+16% YoY) with only ~1% global volume growth — 2x+ operating leverage doing the work. Management reaffirmed the FY26 algorithm: 10%+ comparable diluted EPS growth, FCF >$900M, ~$800M capital return. Q2 tests whether EMEA stays the accelerator, SA holds the April rebound, and NCA stays capacity-tight into Millersburg (2027 volume story).


1. Executive summary

Ball is the pure-play global aluminum beverage can leader after the Aerospace divestiture. The investment case is substrate share gains (the can winning vs plastic/glass) + regional operating leverage + aggressive capital return — not heroic unit volume.

Growth trajectory — leverage over volume. The last print (Q1 2026, reported 2026-05-05) was a clean double-beat: net sales $3,603M (+16.3% YoY vs $3,097M); comparable diluted EPS $0.94 vs $0.76 (+23.7%); comparable operating earnings $387M. Segment sales: NCA $1,776M, EMEA $1,111M, SA $585M. Pattern: 8 of 9 quarters EPS beats / 0 misses; Q1 was a true double-beat (rev +5% vs Street, EPS +9%).

Key watch items into Q2 2026:

Classification: CONSERVATIVE algorithm guider, CONSISTENT beater — reaffirmed (not raised) at Q1; beat culture intact across 8/9 EPS prints.

Data sourced from Daloopa (company_id 289); FMP consensus; Ball IR / Q1 2026 review workspace. Bloomberg/VA not connected this session.

2. Guidance & estimates

How to read BALL "guidance": Ball does not issue formal quarterly revenue or EPS ranges. It guides a full-year algorithm (comparable diluted EPS growth, FCF, capex, capital return, leverage) plus qualitative regional volume color. The Q2 print is measured against (a) Street consensus for the quarter and (b) language that holds, tightens, or softens the 10%+ floor.

FY2026 guide (set Feb'26, reaffirmed Q1'26) Guide FY2025 actual / context Read-through
Comparable diluted EPS growth 10%+ $3.57 FY25 → ~$3.93+ floor Street ~$4.05 above floor; algorithm sandbagged
Free cash flow >$900M FY25 FCF $788M Back-half loaded; Q1 FCF seasonally deep negative
Capex ~$600M Includes Millersburg Capacity investment year; 2027 NCA unlock
Capital return ~$800M ($600M+ buyback) Step-down vs FY25 for delever Deleveraging year; EPS still buyback-supported
Net leverage ~2.7x → glide 2.5x Post-Aerospace capital structure Return pace subordinated to leverage path
Corp undistributed ~$175M +$15M FX vs Feb Only modeling delta at Q1 reaffirm
Millersburg / ends startup ~$35M H2 drag Mostly Q3-weighted Already in the 10%+ math; watch for overrun language

Q2 2026 Street (FMP): Comp EPS ~$0.99 (FMP $0.989) · Sales ~$3.69B. That is ~+10% EPS YoY vs Q2'25 $0.90 and ~+10% sales vs $3,338M. No formal quarterly guide — the print is judged on beat quality + algorithm language + regional volume commentary.

FY2026 guide and actuals: Daloopa (company_id 289). Consensus: FMP analyst-estimates. Bloomberg/Visible Alpha not connected this session.

3. Detailed key metrics

3a. Current quarter (Q2 2026) — consensus vs. Q2 2025 comp

Ball does not guide the quarter; columns show Street, the prior-year comp, and the most recent actual for context.

Metric Q2'25 actual (comp) Q2'26 consensus YoY (cons.) Framing
Net sales $3,338M ~$3.69B +~10% Price/mix + aluminum pass-through; volume still muted
Comp diluted EPS $0.90 ~$0.99 +~10% Leverage + buybacks; in-line with algorithm path
NCA sales $1,613M n/a Capacity-capped; Q1'26 $1,776M
EMEA sales $1,050M n/a Accelerator; Q1'26 $1,111M
SA sales $477M n/a Rebound test; Q1'26 $585M

3b. Historical quarterly trend (8 quarters) — trajectory over absolutes

All figures $M unless noted. YoY rows use same-quarter prior year (not QoQ).

Metric Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26
Net sales ($M) 2,959 3,082 2,880 3,097 3,338 3,379 3,347 3,603
Net sales YoY % +12.8% +9.6% +16.2% +16.3%
Comp EPS ($) 0.74 0.91 0.84 0.76 0.90 1.02 0.91 0.94
Comp EPS YoY % +21.6% +12.1% +8.3% +23.7%

Interpretation: sales growth has re-accelerated into the mid-teens (Q4'25 +16.2%, Q1'26 +16.3%) while EPS growth remains well above the 10% algorithm floor in most recent quarters. Q2'25 itself was already a strong comp (+12.8% sales / +21.6% EPS vs Q2'24), so the Street's ~+10% ask for Q2'26 is a softer step relative to the recent run-rate — another reason the algorithm still looks sandbagged if leverage holds. FY25 net sales $13,161M; FY25 comp EPS $3.57.

3c. Segment snapshot — NCA / EMEA / SA

Segment Q2'25 sales Q1'26 sales Setup into Q2'26
North & Central America (NCA) $1,613M $1,776M Capacity-capped until Millersburg 2027 volume; sold-out utilization is the near-term ceiling
EMEA $1,050M $1,111M Primary accelerator; volume expected above 3–5% LT; Benepack incremental; best margin runway
South America (SA) $477M $585M Q1 OpE soft; April +20% YoY volume color must land in Q2 to prove timing, not demand break

3d. FQ+1 (Q3 2026) and FY bridge

Period What matters Note
Q3 2026 Millersburg + ends-domestication ~$35M startup drag peaks Already inside 10%+ algorithm; watch for cost overrun language
FY2026 10%+ EPS floor; FCF >$900M; ~$800M returns Street ~$4.05 still above floor; FCF 2H-loaded
FY2027 structural Millersburg NCA volume unlock; >90% contracted Capacity, not demand, is the multi-year bridge
Quarterly & FY figures: Daloopa (company_id 289) for actuals; Q2/FY consensus from FMP. Segment commentary from Q1 2026 call / prior review workspace.

4. Setup analysis — management commentary & tone

The setup in one paragraph: management enters Q2 having reaffirmed the full-year 2026 algorithm at Q1 — 10%+ comparable EPS, FCF >$900M, ~$800M capital return — with only a +$15M FX corporate-cost modeling delta vs February. Tone on the Q1 call was confident on global can share gains, operational excellence offsetting energy/chemicals inflation, and aluminum pass-through described as effectively immediate. EMEA operating leverage was the explicit accelerator; NCA remains constrained until Millersburg 2027 volume. The quality-of-growth caveat from Q1 still stands: volume contribution to sales collapsed vs Q4'25, so most recent growth is price/mix and pass-through — Q2 must show whether April's +MSD enterprise volume (and SA +20%) re-accelerates the unit line.

Tone trajectory: post-Aerospace pure-play messaging is consistent — "the can is winning in every region," substrate share as the secular, BBS cost-out (~75% of $500M delivered, completes YE26 a year early). CEO/CFO transition (Lewis/Rabbitt) is still early; the Q1 reaffirm without a raise is classic sandbag discipline, not caution on demand.

Management-quality read: hit-the-algorithm culture with a conservative floor; beat streak (8/9) supports the claim that the 10%+ is a floor, not a stretch. Risks cluster in (1) consumer packaging weakness if inflation hits beverage categories, (2) Millersburg startup cost overruns beyond $35M, (3) SA snap-back fails, (4) buyback pace vs leverage-target conflict.

FY2026 metric Status at Q1'26 Confidence into Q2 Why
10%+ comp EPS growth Reaffirmed High Q1 +24% YoY; Street above floor; beat culture intact
FCF >$900M Reaffirmed Medium 2H-loaded; seasonal Q1 was deeply negative — path, not print, is the tell
EMEA volume above LT Guided qualitatively Medium-high Q1 +23% sales / +40% OpE; Benepack incremental
NCA capacity path Sold out until Millersburg Medium $35M H2 drag known; 2027 volume is the unlock, not Q2
SA volume normalization April color constructive Medium Must print in Q2; Q1 OpE was the soft spot

What to listen for on Aug 4 (tone tells):

(1) Any raise or tightening of the 10%+ floor — a raise would be the genuine upside surprise. (2) Enterprise and SA volume cadence vs April color. (3) EMEA margin runway language (still "most explicit" or walked back). (4) Millersburg commission timing and whether the $35M H2 drag is still the right number. (5) FCF path into >$900M — working-capital and aluminum-price timing. (6) Capital-return cadence vs 2.7x leverage glide.

Tone/commentary from Ball Q1 2026 earnings materials and prior review workspace; fundamentals via Daloopa (company_id 289).

5. Key catalysts
Catalyst Latest KPI Expectation into Q2'26 / beyond Direction
Millersburg NA capacity Late'26 commission; ~$35M H2 startup in guide Unlocks NCA volume in 2027; >90% contracted Positive (LT)
EMEA volume / margin runway Q1 +23% sales / +40% OpE; lowest profit-per-can Above 3–5% LT volume in 2026; Benepack ramps 2027 Positive
$600M+ buyback / algorithm EPS ~$800M total return FY26 EPS support under 10%+ floor while delevering Positive
FCF >$900M delivery >$900M guided; FY25 $788M 2H-loaded conversion confirms cash algorithm Watch
SA volume normalization Q1 OpE soft; April +20% YoY color Proves Q1 was timing, not structural demand break Watch
Aluminum / Section 232 Pass-through; Q1 net-neutral to slight + Filled cans not on derivatives list — structural positive vs peers Neutral / +
Substrate share (can winning) 2025 US cans +2% while other substrates declined >2% Secular mix shift; EPR / recycled-content regulation tailwind Positive (LT)

Bull case

EPS >$1.02 + EMEA/SA strong + volume re-accelerates + FCF path language firm → algorithm de-risked; optional raise of the 10%+ floor is the full win.

Bear case

Volume air-pocket persists, SA rebound fails, Millersburg cost language creeps above $35M → near-term de-rate into the H2 startup drag even if the 10%+ floor is still held.

Cited fundamentals via Daloopa (company_id 289); Ball Q1 2026 materials; FMP consensus.

6. News analysis

Ex-earnings newsflow since the Q1 report (2026-05-05), most recent first. The print window itself is the primary catalyst; industry aluminum/Section 232 remains the structural backdrop.

Date Item Earnings read-through
Jul 6, 2026 Q2 results set for Aug 4 BMO; call 8:30 a.m. ET Confirms calendar; Street models ~$0.99 / ~$3.69B into the print.
May 5, 2026 Q1 double-beat; FY26 algorithm reaffirmed (10%+ EPS, FCF >$900M) Thesis confirmation print: rev $3.60B / EPS $0.94; only +$15M FX corp delta vs Feb.
Apr 2026 Section 232 aluminum restructure; filled cans not added to derivatives list Mgmt framed net-neutral to slight positive; pass-through model intact — reduces tariff P&L noise vs peers.
Feb 2026 Benepack (€184M, 80% stake, BE+HU) closed Flat 2026 contribution; ramps 2027 — EMEA capacity/optionality, not a Q2 EPS driver.
Ongoing BBS $500M cost-out ~75% delivered; completes YE26 (1 yr early) Supports leverage-over-volume narrative; remaining ~25% is incremental margin insurance.

Read-through: newsflow is quiet outside the earnings calendar — constructive for a compounder where the algorithm and capacity path are the story. No product recalls, demand shocks, or guide drama in the window. Peers CCK / AMBP typically print nearby; packaging read-through is secondary to Ball's own volume/mix print.

Sources: Ball IR / Q1 2026 release and call; Section 232 company commentary; prior BALL Q1 review workspace. Data sourced from Daloopa (company_id 289).

7. Beat / miss track record

Ball has been a consistent beater on comparable EPS: 8 of 9 quarters beats / 1 in-line / 0 misses in the recent series, with 4-of-4 L4Q revenue beats post-Aerospace divestiture. Q1 2026 was a true double-beat (rev +5.0% vs Street $3.43B; EPS +9.3% vs ~$0.86).

Quarter Comp EPS actual Street est. (approx.) Surprise Result Revenue
2025 Q2 $0.90 $0.87 +$0.03 / +3% Beat Beat
2025 Q3 $1.02 ~$1.02 In-line In-line Beat
2025 Q4 $0.91 $0.90 +$0.01 Beat Beat
2026 Q1 $0.94 ~$0.86 +$0.08 / +9.3% Beat Beat +5%

Pattern verdict — consistent beater, sandbagged algorithm. Magnitudes are typically modest (+3–9%) rather than blowouts — classic "beat the conservative Street, reaffirm the floor" behavior. Base case into Aug 4: another modest EPS beat + algorithm reaffirm. Raise of the 10%+ floor would be the upside surprise; any cut is the break case. The beat mechanism is cost discipline + operating leverage + buybacks, only partially dependent on unit volume.

Actuals via Daloopa (company_id 289). Street estimates are press/FMP-reported consensus at each print (best-effort; Bloomberg & Visible Alpha not connected). Data sourced from Daloopa.

8. Preview conclusion
Scenario Shape Implication
Bull EPS >$1.02 + EMEA/SA strong + volume re-accel + FCF path firm (optional 10%+ raise) Algorithm de-risked; 2027 capacity story brought forward in narrative
Base ~$0.99–1.01 + reaffirm 10%+ / FCF >$900M Grind on buybacks and leverage path; H2 Millersburg noise still ahead
Bear Volume miss + SA fails + startup cost creep language Near-term de-rate into H2 drag even if floor still held

Bottom line: Quality industrial compounder with a sandbagged 10%+ floor, proven beat culture (8/9), and a clear multi-year bridge via Millersburg NCA capacity. Own through the H2 startup noise for the 2027 volume unlock; Q2 is about durability of leverage and regional volume, not discovering the can-share story.

Data sourced from Daloopa (company_id 289). FMP for consensus. Prepared 2026-08-01 for the 2026-08-04 print.